Crown Laboratories Acquires Select Consumer Healthcare Brands From Glaxosmithkline
Hildred Capital Portfolio Company Enhances OTC Skin Care Product Offerings
Johnson City, TN??Crown Laboratories, Inc. (?Crown Laboratories?), a leading, fully integrated skin care company and Hildred Capital Partners LLC (?Hildred?) portfolio company, today announced it has acquired North American distribution rights of five (5) OTC consumer brands from GlaxoSmithKline (?GSK?).
GSK?s consumer healthcare portfolio has long been regarded as high quality, safe and effective, maintaining a quality image and loyal base of consumers. OTC medications allow practitioners and their patients the ability to access therapeutic products while reducing the burden of prescription drug costs on the healthcare system. The products expand Crown Laboratories? consumer portfolio by adding #1 in category brands that treat multiple conditions. The acquired portfolio includes:
- PanOxyl:?#1 Dermatologist recommended daily acne wash
- Sarna:?#1 Dermatology recommended anti-itch lotion
- Zeasorb:?#1 Dermatologist recommended anti-fungal and prevention product
- Desenex:?Anti-fungal powder for athlete?s foot
- Mineral Ice:?Leading pain-relieving gel